| P50 | author | Sin-Hyeog Im | Q39923881 |
| | Garima Sharma | Q92540704 |
| P2860 | cites work | Microbial exposure during early life has persistent effects on natural killer T cell function | Q24604308 |
| | Barrier Epithelial Cells and the Control of Type 2 Immunity | Q26801045 |
| | Risk and safety of probiotics | Q28087466 |
| | Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Q28241661 |
| | Low diversity of the gut microbiota in infants with atopic eczema | Q28254907 |
| | Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 |
| | Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota | Q29618128 |
| | Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 |
| | Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders | Q33719638 |
| | A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force | Q34090755 |
| | Extreme genome reduction in symbiotic bacteria | Q34230656 |
| | Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials | Q34479357 |
| | Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis | Q34533028 |
| | Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children | Q34537196 |
| | Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease | Q34557285 |
| | Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial | Q34750864 |
| | World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics | Q35018033 |
| | Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 |
| | Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 |
| | Breast milk, microbiota, and intestinal immune homeostasis | Q35327381 |
| | The probiotic mixture IRT5 ameliorates age-dependent colitis in rats | Q35613069 |
| | Effect of probiotics on the treatment of children with atopic dermatitis | Q35942292 |
| | Dynamics of Gut Microbiota According to the Delivery Mode in Healthy Korean Infants. | Q37039581 |
| | Probiotics and food allergy | Q37070681 |
| | A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis | Q37387330 |
| | Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice | Q37514864 |
| | Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice | Q37571321 |
| | Update on risk factors for food allergy | Q37998676 |
| | Gut microbiome and innate immune response patterns in IgE-associated eczema. | Q38390191 |
| | Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: A meta-analysis | Q38459877 |
| | The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies | Q38733182 |
| | Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling | Q39323642 |
| | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. | Q39370710 |
| | Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial | Q39619929 |
| | Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells | Q40140592 |
| | Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial | Q40398847 |
| | A Probiotic Preparation Alleviates Atopic Dermatitis-Like Skin Lesions in Murine Models | Q40594500 |
| | Foxp3(+) regulatory T cells are expanded in severe atopic dermatitis patients. | Q41080079 |
| | Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Q41435416 |
| | A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of CD4+Foxp3+ T cells | Q41643868 |
| | Bugging allergy; role of pre-, pro- and synbiotics in allergy prevention | Q42001132 |
| | Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? | Q44138178 |
| | Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing | Q44802067 |
| | Shared mechanisms among probiotic taxa: implications for general probiotic claims | Q44876989 |
| | A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice | Q44981241 |
| | Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials | Q46875868 |
| | Clinical Effect of IRT-5 Probiotics on Immune Modulation of Autoimmunity or Alloimmunity in the Eye. | Q47103888 |
| | Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial | Q47586019 |
| | Children with atopic dermatitis show clinical improvement after Lactobacillus exposure | Q48052777 |
| | Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis | Q48063550 |
| | Anti-inflammatory potential of a heat-killed Lactobacillus strain isolated from Kimchi on house dust mite-induced atopic dermatitis in NC/Nga mice. | Q48249791 |
| | Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study | Q48499942 |
| | Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years | Q48543528 |
| | Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children | Q50073094 |
| | Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. | Q51758506 |
| | Therapeutic potential of Lactobacillus plantarum CJLP133 for house-dust mite-induced dermatitis in NC/Nga mice. | Q53370711 |
| | Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. | Q54357507 |
| | Characteristics of peripheral blood CD4+CD25+ regulatory T cells and related cytokines in severe atopic dermatitis | Q56894975 |
| | Administration of a probiotic with peanut oral immunotherapy: A randomized trial | Q57776766 |
| | Probiotics Reduce Gut Microbial Translocation and Improve Adult Atopic Dermatitis | Q57997347 |
| | Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response | Q59302315 |
| | The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention | Q79920849 |
| | Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome | Q84085105 |
| | A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years | Q84387158 |
| | Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model | Q86093323 |
| | Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis | Q86679762 |
| | Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial | Q86689238 |
| | A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis | Q87421515 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 575-590 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Allergy, Asthma & Immunology Research | Q13429052 |
| P1476 | title | Probiotics as a Potential Immunomodulating Pharmabiotics in Allergic Diseases: Current Status and Future Prospects | |
| P478 | volume | 10 | |